What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS

Progress Educational Trust
Wellcome Collection, 183 Euston Road, London NW1 2BE
4 July 2017
This public event was organised by the Progress Educational Trust (PET) in partnership with Genomics England, the organisation established by the UK Government to deliver the 100,000 Genomes Project.
The event launched the Generation Genome report by the UK's Chief Medical Officer, who was a keynote speaker. The event also launched a new phase of the Genomics Conversation, a programme of activities which involves the public and stakeholders in discussions about key issues in genomic medicine.
Below, you can watch a film of the event produced by the education charity WORLDwrite. (If you cannot see the film below, click here to view it.)
The NHS Chief Scientific Officer adapted her speech at the event into an article for PET's flagship publication BioNews.
Also on BioNews, read a synopsis of the event proceedings (by Dr Rachel Brown ) and an article about the publication of the Generation Genome report (by Jennifer Willows). Elsewhere, the event received media coverage in Prospect magazine and in the Pharmaceutical Journal.
The next event in the Genomics Conversation programme will be 'Talking Genomics with Patients', taking place in Birmingham on the evening of Tuesday 5 March. Details can be found here.
Other events in the Genomics Conversation programme have included 'What Does Consent Mean for Generation Genome?', 'With Great Genomic Data Comes Great Responsibility', 'How Do We Make Genomics Everybody's Business?' and 'Whose Genome Is It Anyway? Big Data and Your DNA'. Films of these events can be found on PET's YouTube channel here.

The UK is a leader in genomic medicine, an approach to medicine in which our genomic information plays a central role in understanding, preventing, diagnosing and treating disease. The NHS is the first healthcare system in the world seeking to commission routine whole genome testing for rare diseases and cancer, work which is currently being pioneered by the 100,000 Genomes Project and by NHS England's 13 Genomic Medicine Centres.
Genomic medicine also stands to have a transformative effect on healthcare and the NHS more widely, and some benefits are already being seen. This public event saw a panel of experts - including the UK's Chief Medical Officer, Professor Dame Sally Davies - discuss what has been learned to date in genomic medicine and research, the challenges that still need to be overcome, and the benefits we stand to gain if genomics is successfully embedded into mainstream healthcare.
Questions explored included:
What progress has been made with genomics in relation to rare diseases, cancers and infectious diseases? What other conditions could benefit from genomic medicine?
How solid are the foundations for a mainstream genomic medicine service in today's NHS? What groundwork remains to be done?
When is it appropriate and useful to combine clinical services with research projects, for example the 100,000 Genomes Project? When should these things be kept distinct?
What do patients think about their genomic data being shared with researchers in the public and private sectors? What sort of consent are they required to give? What are their hopes and fears, and how can these be addressed?
How can we best support clinicians in different disciplines in making use of genomics? And how can we involve other healthcare workers, such as nurses?

Professor Dame Sally Davies
Chief Medical Officer at the UK Government
Professor Sue Hill
Chief Scientific Officer at NHS England, and Senior Responsible Officer for the NHS Genomics Programme
Sir Stephen O'Rahilly
Professor of Clinical Biochemistry and Medicine, Head of Clinical Biochemistry and Director of Metabolic Research Laboratories at the University of Cambridge
Michael Parker
Professor of Bioethics, and Director of the Ethox Centre and the Centre for Ethics, Innovation, Globalisation and Medicine, at the University of Oxford

Mark Henderson
Director of Communications at the Wellcome Trust

Partners and supporters: